Get the Stockscreener App
30.14
3.74%
-1.17
Zai Lab Limited Adr stock is traded at $30.14, with a volume of 626.78K.
It is down -3.74% in the last 24 hours and down -5.34% over the past month.
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
See More
Previous Close:
$31.31
Open:
$30.99
24h Volume:
626.78K
Relative Volume:
0.57
Market Cap:
$33.25B
Revenue:
$418.33M
Net Income/Loss:
$-252.07M
P/E Ratio:
-12.56
EPS:
-2.4
Net Cash Flow:
$-238.84M
1W Performance:
-3.77%
1M Performance:
-5.34%
6M Performance:
+4.47%
1Y Performance:
+65.70%
1-Day Range:
$29.82
$31.20
1-Week Range:
$29.82
$31.34
52-Week Range:
$16.01
$39.77
Zai Lab Limited Adr Stock (ZLAB) Company Profile
Name
Zai Lab Limited Adr
Sector
Industry
Phone
862161632588
Address
4560 JINKE ROAD, SHANGHAI
Compare ZLAB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZLAB
Zai Lab Limited Adr
|
30.14 | 3.43B | 418.33M | -252.07M | -238.84M | -2.40 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-03-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-14-23 | Initiated | Morgan Stanley | Overweight |
| Aug-10-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-21-22 | Initiated | Macquarie | Outperform |
| Oct-12-21 | Initiated | Bernstein | Mkt Perform |
| Apr-28-20 | Initiated | Goldman | Buy |
| Apr-15-20 | Initiated | Guggenheim | Buy |
| Jul-12-19 | Initiated | BofA/Merrill | Buy |
| Jul-05-19 | Initiated | Macquarie | Outperform |
| Jan-29-19 | Initiated | Credit Suisse | Outperform |
| Nov-21-18 | Initiated | Jefferies | Buy |
| Jun-21-18 | Resumed | Leerink Partners | Outperform |
| Feb-14-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-16-17 | Initiated | JP Morgan | Neutral |
| Oct-16-17 | Initiated | Leerink Partners | Outperform |
View All
Zai Lab Limited Adr Stock (ZLAB) Latest News
Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan
Zai Lab Announces Participation in Investor Conferences in June 2025 - Business Wire
Northern Trust Corp Increases Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Quantinno Capital Management LP Reduces Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
BNP Paribas Financial Markets Purchases 18,472 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer - BioSpace
Barclays PLC Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Cantor Fitzgerald Expects Increased Earnings for Zai Lab - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Q1 2025 Earnings Call Transcript - Insider Monkey
Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - MSN
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight - GuruFocus
Trading Day Triumph: Zai Lab Limited ADR (ZLAB) Ends at 29.38, a -5.07 Surge/Plunge - DWinneX
Raymond James Financial Inc. Makes New $1.03 Million Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Limited (NASDAQ:ZLAB) Shares Bought by Invesco Ltd. - Defense World
Envestnet Asset Management Inc. Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Geode Capital Management LLC Boosts Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Post-Trade Analysis: VICI Properties Inc (VICI) Climbs 0.06, Closing at 32.26 - DWinneX
Market Insights: Canadian Solar Inc (CSIQ)’s Notable Drop of -1.73, Closing at 9.65 - DWinneX
Daily Market Movement: Faraday Future Intelligent Electric Inc (FFAI) Sees a -0.76 Decrease, Closing at 1.30 - DWinneX
In the Green: Zai Lab Limited ADR (ZLAB) Closes at 31.84, Up/Down -1.82 from Previous Day - DWinneX
Closing Bell Recap: C.H. Robinson Worldwide, Inc (CHRW) Ends at 88.33, Reflecting a -0.84 Downturn - DWinneX
Zai Lab Limited ADR (ZLAB) is looking forward to a strong quarter - Sete News
Wells Fargo & Company MN Grows Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World
Zai Lab Ltd Announces 2025 Annual General Meeting - TipRanks
Zai Lab Limited ADR (ZLAB) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025 - Business Wire
Ratios Reveal: Breaking Down Packaging Corp Of America (PKG)’s Financial Health - DWinneX
Analytical Overview: GE Vernova Inc (GEV)’s Ratios Tell a Financial Story - DWinneX
Financial Health Check: Examining Bellring Brands Inc (BRBR)’s Key Ratios - DWinneX
Deeper Dive: Understanding Concentrix Corp (CNXC) Through its Various Ratios - DWinneX
A stock that deserves closer examination: Zai Lab Limited ADR (ZLAB) - uspostnews.com
Analytical Overview: Erasca Inc (ERAS)’s Ratios Tell a Financial Story - DWinneX
Ratios Reveal: Breaking Down Check Point Software Technologies Ltd (CHKP)’s Financial Health - DWinneX
Financial Metrics Unveiled: Orchestra BioMed Holdings Inc (OBIO)’s Key Ratios in the Spotlight - DWinneX
Ratios in Focus: Analyzing Watsco Inc (WSO)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Theratechnologies Inc (THTX)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Financial Health Check: Examining Astronics Corp (ATRO)’s Key Ratios - DWinneX
Zai Lab Limited (NASDAQ:ZLAB) Shares Acquired by Bank of Montreal Can - Defense World
Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting - Business Wire
Zai Lab Limited (NASDAQ:ZLAB) Position Boosted by Renaissance Technologies LLC - Defense World
Equitable Holdings Inc [EQH] Insider Lane Nick sells 5,000 Shares – Company Insider Activity - knoxdaily.com
Palantir Technologies Inc [PLTR] Insider Stat Lauren Elaina Friedman sells 800 Shares for $800 - knoxdaily.com
Zai Lab Limited ADR [ZLAB] Insider Smiley Joshua L sells 3,354 Shares – Latest News - knoxdaily.com
Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors - Business Wire
JPMorgan Chase & Co. Buys 23,510 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World
All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy - Yahoo Finance
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? - MSN
Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025 - Yahoo Finance
Zai Lab (NASDAQ:ZLAB) Shares Gap Up – Should You Buy? - Defense World
Asian ADRs Shine As Zai Lab And CNFinance Lead The Gains - Finimize
Zai Lab Limited Adr Stock (ZLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.32%
1.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):